Home › Kanser sa Prostate › Michigan › Grand Rapids
Pag-aaral pangklinika para sa Kanser sa Prostate sa Grand Rapids, MI
19 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Grand Rapids (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Nagre-recruitPhase 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Nagre-recruitPhase 3
- Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Nagre-recruitPhase 1
- Start Midwest, Grand Rapids
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1
- START Midwest, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
- BAMF Health Inc., Grand Rapids
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
Nagre-recruitPhase 2/3
- BAMF Health, Grand Rapids
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Nagre-recruitPhase 3
- Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Nagre-recruitPhase 1/2
- GSK Investigational Site, Grand Rapids
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1
- BAMF Health, Grand Rapids
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Nagre-recruitPhase 3
- BAMF Health, Grand Rapids
- Corewell Health, Grand Rapids
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Nagre-recruitPhase 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- Research Site, Grand Rapids
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Nagre-recruitPhase 3
- Research Site, Grand Rapids
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Nagre-recruitPhase 1/2
- START, Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Nagre-recruitPhase 1/2
- START Midwest, Grand Rapids
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- Spectrum Health at Butterworth Campus, Grand Rapids
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN43 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Grand Rapids
- Non-Small Cell Lung Cancer44 pag-aaral
- Colorectal Cancer40 pag-aaral
- Kanser (lahat ng uri)28 pag-aaral
- Kanser sa Suso26 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Metastatic Cancer22 pag-aaral
- Kanser ng Endometrium18 pag-aaral
- Kanser sa Tiyan18 pag-aaral
- Kanser sa Pancreas18 pag-aaral
- Melanoma17 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg15 pag-aaral
- Triple-Negative Breast Cancer15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.